Human T-cell Leukemia Virus (HTLV) is a highly neglected virus that causes leukemia and neurodegeneration, with no current treatment. The researcher has developed siRNA-based RNA drugs that suppress the virus by up to 90%, prevent reactivation, and can be delivered via a nasal spray. This breakthrough could become the first effective antiviral therapy for HTLV.